ATL ULTRASOUND INC
10-Q, 1998-05-15
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Previous: TELEMUNDO GROUP INC, 10-Q, 1998-05-15
Next: BAYWOOD INTERNATIONAL INC, 10QSB, 1998-05-15




                                
               SECURITIES AND EXCHANGE COMMISSION
                                
                     Washington, D.C.  20549
_________________________________________________________________
                                
                            FORM 10-Q
                                
                                
      [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)
            OF THE SECURITIES EXCHANGE ACT OF 1934
         
         For the Quarterly Period Ended April 3, 1998
         
          TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)
            OF THE SECURITIES EXCHANGE ACT OF 1934
         
         For the Transition Period From _____ to _____
_________________________________________________________________
                                
                 Commission File Number 0-15160
                                
                      ATL ULTRASOUND, INC.
     (Exact name of registrant as specified in its charter)


          Washington                         91-1353386
   (State of incorporation)      (IRS Employee Identification No.)

22100 Bothell-Everett Highway
     Post Office Box 3003
     Bothell, Washington                     98041-3003
    (Address of principal                    (ZIp Code) 
      executive offices)     (Zip Code)

                         (425) 487-7000
                       (Telephone number)
                                
                                
 Common stock, $0.01 par value; 14,603,555 shares outstanding as
                         of May 1, 1998
                                
                                
Indicate  by check mark whether the registrant (1) has filed  all
reports  required  to be filed by Section  13  or  15(d)  of  the
Securities  Exchange Act of 1934 during the preceding  12  months
(or  for such shorter period that the registrant was required  to
file  such  reports),  and (2) has been subject  to  such  filing
requirements for the past 90 days.

                      YES    [X]        NO [ ]

<PAGE>
                                
                      ATL ULTRASOUND, INC.
                        TABLE OF CONTENTS
                                
                                
                                
                                
PART I    Financial Information                                   Page No.
          ---------------------                                   --------
 
Item 1.   Financial Statements
          --------------------
          Condensed Consolidated Balance Sheets -
            April 3, 1998 (Unaudited) and December 31, 1997..........3

          Condensed Consolidated Statements of Operations
          (Unaudited) - Three Months Ended April 3, 1998 
          and March 28,  1997........................................4

          Condensed Consolidated Statements of Cash Flows
          (Unaudited) - Three Months Ended April 3, 1998 
          and March 28,  1997 .......................................5

          Notes to Condensed Consolidated Financial  Statements......6

Item 2.   Management's Discussion and Analysis of Financial
          -------------------------------------------------
          Condition and Results of Operations........................10
          -----------------------------------


PART II   Other Information
          -----------------

Item 1.   Legal Proceedings..........................................14
          -----------------

Item 2.   Changes in Securities......................................14
          ---------------------

Item 3.   Defaults Upon Senior Securities............................14
          -------------------------------

Item 4.   Submission of Matters to a Vote of Security Holders........14
          ---------------------------------------------------

Item 5.   Other Information..........................................14
          -----------------

Item 6.   Exhibits and Reports on Form 8-K...........................14
          -------------------------------- 

                                  2
<PAGE>

PART I  Financial Information
- ------  ---------------------

Item 1. Financial Statements
        --------------------

                      ATL ULTRASOUND, INC.
              CONDENSED CONSOLIDATED BALANCE SHEETS
                                
- -----------------------------------------------------------------  
(In thousands)                              4/3/98      12/31/97
- -----------------------------------------------------------------
                                          (Unaudited)
                            ASSETS
                                                        
CURRENT ASSETS                                          
 Cash and cash equivalents                 $ 43,113    $ 30,821
 Receivables, net                           117,243     136,351
 Inventories                                 97,307      98,677
 Prepaid expenses                             3,831       2,207
 Deferred income taxes, net                  13,735      13,668
                                           --------------------
      Total current assets                  275,229     281,724
                                                        
PROPERTY, PLANT AND EQUIPMENT, NET           76,380      74,630
OTHER ASSETS, NET                             5,633       5,456
                                           --------------------
                                          $ 357,242   $ 361,810
                                           ====================
                                                        
                               
             LIABILITIES AND SHAREHOLDERS' EQUITY
                                                        
CURRENT LIABILITIES                                     
 Short-term borrowings                    $     295   $     654
 Current portion of long-term debt              456         449
 Accounts payable and accrued expenses       66,488      80,529
 Dividend payable                            30,331          --
 Deferred revenue                            15,645      15,831
 Taxes on income                              7,000       1,457
                                          --------------------
      Total current liabilities             120,215      98,920
                                                        
LONG-TERM DEBT                               12,166      12,307
OTHER LONG-TERM LIABILITIES                  21,089      20,862
SHAREHOLDERS' EQUITY                        203,772     229,721
                                           --------------------
                                          $ 357,242   $ 361,810
                                           ====================
         
- ---------------------------------------------------------------- 
COMMON SHARES OUTSTANDING                   14,590       14,413
- ----------------------------------------------------------------
                                
 See accompanying notes to condensed consolidated financial statements.

                                3
<PAGE>

                      ATL ULTRASOUND, INC.
         CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
                           (Unaudited)
                                
                                
                                            Three months ended
- ----------------------------------------------------------------
(In thousands, except per share data)       4/3/98      3/28/97
- ----------------------------------------------------------------           
REVENUES                                                
 Product sales                             $ 81,999    $ 77,714
 Service                                     23,417      22,404
                                           --------------------
                                            105,416     100,118
                                           --------------------
COST OF SALES                                           
 Cost of product sales                       38,315      39,816
 Cost of service                             14,304      12,522
                                           --------------------
                                             52,619      52,338
                                                        
GROSS PROFIT                                 52,797      47,780
                                                        
OPERATING EXPENSES, NET                                 
 Selling, general and administrative         33,656      30,308
 Research and development                    14,934      14,764
 Other expense, net                           1,619         356
                                           --------------------
                                             50,209      45,428
                                           --------------------

INCOME FROM OPERATIONS                        2,588       2,352
                                                        
Interest income                                 426         956
Interest expense                               (286)       (742)
                                           --------------------
          
INCOME BEFORE INCOME TAXES                    2,728       2,566
                                                        
Income tax expense                              545         514
                                           --------------------                
NET INCOME                                  $ 2,183     $ 2,052
                                           ====================              
                                                        
Net income per share:                                   
Basic                                       $  0.15     $  0.15
Diluted                                     $  0.15    $   0.14
                                                        
Weighted-average common shares 
 and equivalents outstanding:
 Basic                                       14,303      13,971
 Diluted                                     15,010      14,836
- ----------------------------------------------------------------           
See accompanying notes to condensed consolidated financial statements.

                                  4
<PAGE>

                      ATL ULTRASOUND, INC.
         CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
                           (Unaudited)
                                
                                                   Three months ended
- -------------------------------------------------------------------------
(In thousands)                                     4/3/98      3/28/97
- -------------------------------------------------------------------------
OPERATING ACTIVITIES                                
   Net income                                     $  2,183    $  2,052
    Adjustments to reconcile net income 
    to cash provided by operating activities:
     Depreciation and amortization                   4,280       4,040
     Deferred income tax expense (benefit)             (67)         48
    Changes in:                                        
     Receivables, net                               18,032      18,545
     Inventories                                       910       2,754
     Accounts payable and accrued expenses         (13,556)     (9,456)
     Deferred revenue                                 (117)     (1,799)
     Taxes on income                                 5,557      (1,408)
     Other                                          (1,847)        353
                                                    -------------------
       Cash provided by operations                  15,375      15,129
                                                    
INVESTING ACTIVITIES                                
   Investment in property, plant and equipment      (5,383)     (2,903)
                                                   ------------------- 
       Cash used by investing activities            (5,383)     (2,903)
                                                    
FINANCING ACTIVITIES                                
   Decrease in short-term borrowings                  (359)       (261)
   Repayment of long-term debt                        (134)       (314)
   Repurchase of common shares                        (202)     (1,617)
   Exercise of stock options                         2,936       1,867
                                                    ------------------
       Cash provided (used) by financing activities  2,241        (325)
                                                    
Effect of exchange rate changes                         59          84
                                                    ------------------      
   Increase in cash and cash equivalents            12,292      11,985
                                                    
Cash and cash equivalents, beginning of period      30,821      63,262
                                                    ------------------
Cash and cash equivalents, end of period          $ 43,113    $ 75,247
                                                    ==================
- ----------------------------------------------------------------------
Non-cash financing transaction:                     
   Accrual of capital contribution 
   to SonoSight, Inc.                               30,331       -
- ----------------------------------------------------------------------
                                                    
 See accompanying notes to condensed consolidated financial statements.

                                  5
<PAGE>

                      ATL ULTRASOUND, INC.
      NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
                     (Dollars in thousands)


1. Basis of Presentation

The  accompanying  condensed  consolidated  financial  statements
include  the  accounts  of  ATL  Ultrasound,  Inc.  (ATL),  which
includes  its  subsidiaries and is referred to as the  "Company".
The   Company   is   a  worldwide  leader  in  the   development,
manufacture,  distribution  and  service  of  diagnostic  medical
ultrasound  systems and related accessories  and  supplies.   The
Company  sells its products to hospitals, clinics and  physicians
for  use in radiology, cardiology, women's health care, vascular,
musculoskeletal and intraoperative applications.

The  accompanying condensed consolidated financial statements and
related  notes have been prepared pursuant to the Securities  and
Exchange   Commission  rules  and  regulations  for  Form   10-Q.
Accordingly,   certain   information  and  footnote   disclosures
normally  included in financial statements prepared in accordance
with generally accepted accounting principles have been condensed
or   omitted  pursuant  to  such  rules  and  regulations.    The
accompanying  condensed  consolidated  financial  statements  and
related notes should be read in conjunction with the consolidated
financial  statements and notes thereto incorporated by reference
in the Company's 1997 Form 10-K.

The information furnished reflects, in the opinion of management,
all  adjustments necessary for a fair presentation of the results
for  the  interim  periods presented.  Interim  results  are  not
necessarily indicative of results for a full year.

2. Cash and Cash Equivalents

The  Company considers short-term investments with maturity dates
of  three  months  or  less at the date of purchase  to  be  cash
equivalents for purposes of the statement of cash flows.

3. Inventories

                                       4/3/98     12/31/97
                                      ---------   ---------
       Materials and work in progress $34,471      $36,717
       Finished products               16,991       20,545
       Demonstrator equipment          28,542       23,838
       Customer service                17,303       17,577
                                      ---------   ---------
                                      $97,307      $98,677
                                      =========   =========

                                  6
<PAGE>

                      ATL ULTRASOUND, INC.
      NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
                     (Dollars in thousands)


4. Per Share Data

In  accordance  with Statement of Financial Accounting  Standards
(FAS) No. 128, Earnings Per Share, the Company has reported  both
basic  and  diluted net income per common share for  each  period
presented.  Basic earnings per share (EPS) is calculated based on
the  weighted average number of common shares outstanding  during
the  period.  The computation of diluted EPS includes the  effect
of  all dilutive potential common shares outstanding.  Conversion
of  dilutive  potential common shares is  assumed  based  on  the
average  market  price  of common shares outstanding  during  the
period.   All  previously  reported EPS  have  been  restated  to
conform with the provisions of FAS 128.

The   following  schedule  represents  a  reconciliation  of  the
numerators  and  denominators  of  the  basic  and  diluted   EPS
calculations for the first quarter of 1998 and 1997.

                                            Q1 1998            Q1 1997
                                    ---------------------  ------------------
                                    Income  Shares   EPS   Income Shares  EPS
                                    ---------------------  -------------------
                                                               
Weighted-average shares outstanding         14,451                14,091     
Weighted-average unvested    
 restricted stock                            (148)                  (120)
                                            ------                ------
Basic EPS                           $2,183  14,303  $0.15 $2,052  13,971 $0.15
                             
                                                               
Effect of dilutive securities:
  Restricted stock                              49                    56     
  Common stock equivalents                     658                   809     
                                            ------                ------
                                                               
Diluted EPS                        $2,183   15,010  $0.15 $2,052  14,836 $0.14

Common  stock equivalents totaling 11,000 and 150,000  shares  in
the  first quarter of 1998 and 1997, respectively, were  excluded
from the calculation of diluted EPS as they were antidilutive.

5. Comprehensive Income

In June 1997, the Financial Accounting Standards Board issued FAS
No. 130, Reporting Comprehensive Income, which became effective
for fiscal years beginning after December 15, 1997.  FAS 130
requires that an entity report an amount representing total
comprehensive income in condensed financial statements of interim
periods issued to Company shareholders. Reclassification of financial 
statements for earlier periods provided for comparative purposes is 
required.

                               7
<PAGE>

                      ATL ULTRASOUND, INC.
      NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
                         (Dollars in thousands)


Comprehensive income represents the change in equity of a
business enterprise during a period from transactions and other
events and circumstances from non-owner sources and includes net
income as well as items referred to as other comprehensive income
or loss.  For the periods presented, the only item of other
comprehensive income for the Company is the foreign currency
translation adjustment resulting from the consolidation of
foreign operations.  The table below provides a reconciliation of
net income to total comprehensive income (loss) for each period
presented.

                                       4/3/98     3/28/97
                                     ---------   --------- 
     Net income                        $2,183     $2,052
     Foreign currency translation 
      adjustments resulting in other                  
      comprehensive loss               (1,022)    (2,363)
                                     ---------   ---------
     Comprehensive income (loss)       $1,161      $(311)
                                     =========   =========
At April 3, 1998, the accumulated total of other comprehensive
loss relating to foreign currency translation adjustments was
$7,421.

6.  Reclassifications

Certain   amounts  reported  in  the  previous  year  have   been
reclassified to conform to the 1998 presentation.

7.  Distribution and Subsequent Event

On  February 2, 1998, the Company approved a plan to spin-off its
handheld  business  division  as an independent,  publicly  owned
company  (SonoSight, Inc.) to its shareholders.   A  registration
statement  on Form 10 was filed with the Securities and  Exchange
Commission in the name of SonoSight, Inc. and became effective on
April  2,  1998.   The spin-off was effected through  a  tax-free
distribution of SonoSight shares to ATL shareholders on April  6,
1998  (the "Distribution").  The Company's shareholders  received
one  share of SonoSight common stock for each three shares of the
Company's   common   stock   held.   In   connection   with   the
Distribution,  the  Company contributed to  SonoSight  additional
funding   of  $18,000 in cash on the Distribution date  and  will
contribute  $12,000  in cash in January 1999.   The  Company  and
SonoSight  have entered into a number of agreements to facilitate
the  Distribution  and  the  transition  of  the  company  to  an
independent business.

                                 8

<PAGE>

                      ATL ULTRASOUND, INC.
      NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
                     (Dollars in thousands)
                                
                                
To  date,  there have been no revenues from the sale of  handheld
ultrasound devices. The handheld business has been focused on the
research,   development   and   commercialization   of   handheld
technology and all business activities, including U.S. Government
development contract funding, have been reported in the Company's
operating expenses.  Handheld business division spending  totaled
approximately  $2,500 and $1,000, respectively, for  the  periods
ended  April 3, 1998 and March 28, 1997.  The EPS impact  of  the
handheld business net operating expenses was approximately  $0.13
in  the  first quarter of 1998 and $0.05 in the first quarter  of
1997.   In connection with the Distribution, the Company incurred
stock  distribution expenses of approximately  $1,300.   The  EPS
impact of the stock distribution expenses was approximately $0.07
in the first quarter of 1998.

                               9
<PAGE>

Item 2.     Management's  Discussion and  Analysis  of  Financial
            -----------------------------------------------------
            Condition and Results of Operations
            -----------------------------------

                      RESULTS OF OPERATIONS
                      ---------------------

                                          Three months ended
- ------------------------------------------------------------------------
(In millions except per share data)       4/3/98     3/28/97   % Change
- ------------------------------------------------------------------------
                                                   
Revenues                                  $105.4     $100.1      5.3%
                                                   
Gross Profit                               $52.8      $47.8     10.5%
                                          
Operating Expenses                         $50.2      $45.4     10.5%
                                                   
Net Income                                  $2.2       $2.1      6.4%
                                                   
Diluted Net Income per Share               $0.15      $0.14      5.2%
- ------------------------------------------------------------------------
                                                   
The  Company  reported net income of $2.2 million  or  $0.15  per
share  in  the first quarter of 1998 compared with net income  of
$2.1  million  or $0.14 per share in the first quarter  of  1997.
The  impact  on  net  income and net income per  share  from  the
SonoSight,  Inc.  stock distribution expenses  was  approximately
$1.0  million and $0.07 per share, respectively.  All  per  share
amounts are stated on a diluted basis.

REVENUES AND GROSS PROFIT

The Company's worldwide revenues increased 5.3% to $105.4 million
in  the first quarter of 1998 compared with $100.1 million in the
first  quarter of 1997.  Product sales increased by $4.3  million
or  5.5% in the first quarter of 1998 compared to the same period
in  the  prior year.  The increase in product sales is  primarily
attributable  to  strong worldwide demand for the  Company's  HDI
5000  and  HDI  3000  systems, partially offset  by  the  foreign
exchange  impact  of  the stronger U.S. dollar  on  international
business  and the sale of the Company's image management business
in  the second quarter of 1997.  Service revenues increased  $1.0
million  or 4.5% compared with the first quarter of 1997  due  to
the  continued  growth  in the worldwide installed  base of ATL's 
products.

Gross  profit was $52.8 million in the first quarter of 1998,  an
increase  of  $5.0 million compared with gross  profit  of  $47.8
million  in  the  same quarter of the prior  year.   Total  gross
margin  for the first quarter of 1998 increased to 50.1% compared
with 47.7% in the prior year.  These increases are attributed  to
favorable  product  mix  shift  reflecting  the  benefit  of  the
introduction of the Company's premium-performance HDI 5000 system
which  began  customer shipments in November 1997,  ongoing  cost
reduction programs and manufacturing efficiencies.

                             10
<PAGE>

Item 2.     Management's  Discussion and  Analysis  of  Financial
            -----------------------------------------------------
            Condition and Results of Operations (Continued)
            -----------------------------------------------

OPERATING EXPENSES, NET
- -----------------------

Operating  expenses  increased to  $50.2  million  in  the  first
quarter  of 1998 from $45.4 million in the same period  of  1997.
Selling,  general and administrative expenses were $33.7 million,
an  increase  of  11.0%  over the first  quarter  of  1997.   The
increase   in  selling,  general,  and  administrative   expenses
reflects higher sales volumes over the prior year, start-up costs
related  to  the  establishment of a new  subsidiary  in  Brazil,
increased  handheld  spending  and increased  market  development
expenditures in Asia.  These increases were partially  offset  by
the  favorable  impact of foreign exchange and the  sale  of  the
Company's  image  management business.  Research and  development
(R&D)  expenses  increased 1.2% to $14.9  million  in  the  first
quarter  of 1998 compared with $14.8 million in the first quarter
of  1997.   The  increase in R&D expenses  is  primarily  due  to
increased  expenditures  related to the development  of  handheld
ultrasound  technology offset by the sale of the Company's  image
management  business.  The handheld business has been focused  on
the  research,  development  and  commercialization  of  handheld
technology and all business activities, including U.S. Government
development contract funding, have been reported in the Company's
operating expenses.  Handheld business division spending  totaled
approximately  $2.5 million and $1.0 million,  respectively,  for
the  periods  ended April 3, 1998 and March 28,  1997.   The  EPS
impact  of  the  handheld  business net  operating  expenses  was
approximately $0.13 in the first quarter of 1998 and $0.05 in the
first  quarter of 1997.  Other expense, net was $1.6  million  in
the  first quarter of 1998 compared with $0.4 million in the same
period of the prior year.  The increase in other expense, net  is
primarily  due  to one-time stock distribution expenses  of  $1.3
million  during  the first quarter of 1998 for  the  spin-off  of
SonoSight.  The EPS impact of the stock distribution expenses was
approximately $0.07 in the first quarter of 1998.

INTEREST INCOME AND EXPENSE
- ---------------------------

The Company earned net interest income of $0.1 million during the
first  quarter of 1998 compared with net interest income of  $0.2
million  during  the  same period in 1997.  Net  interest  income
includes  interest income earned on cash balances  available  for
investment  and  extended term receivables,  offset  by  interest
expense  on long-term debt.  1997 interest expense also  includes
post-judgment  interest  expense  accrued  on  patent  litigation
damages which were fully paid in the fourth quarter of 1997.

TAXES AND NET INCOME
- --------------------

For  the  first  quarters of 1998 and 1997, the Company  reported
income  tax  expense  of  $0.5 million, which  represents  a  20%
effective tax rate for U.S. federal, state and foreign income.

                              11

Item 2.     Management's  Discussion and  Analysis  of  Financial
            -----------------------------------------------------
            Condition and Results of Operations (Continued)
            -----------------------------------------------

                 CAPITAL RESOURCES AND LIQUIDITY
                 -------------------------------
        -----------------------------------------------------          
        (In millions)                   4/3/98      12/31/97
        -----------------------------------------------------  
        Cash and cash equivalents       $43.1        $ 30.8
                                                 
        Total Assets                   $357.2        $361.8
                                                   
        Long-term debt                  $12.2        $ 12.3
                                                   
        Shareholders' Equity           $203.8        $229.7
        -----------------------------------------------------
                                                   

Cash  and cash equivalents totaled $43.1 million at April 3, 1998
compared  with $30.8 million at December 31, 1997.  As  shown  in
the  Condensed Consolidated Statement of Cash Flows,  during  the
first  quarter of 1998, the Company generated $15.4 million  from
operating activities while financing activities provided cash  of
$2.2  million.   At  April 3, 1998, receivables,  net,  decreased
$18.0 million and accounts payable and accrued expenses decreased
$13.6  million from December 31, 1997 reflecting seasonally  high
activity levels in the fourth quarter of 1997.  During the  first
quarter  of  1998,  cash of $2.9 million was generated  from  the
exercise of employee stock options.

The  Company repurchased 5,000 shares of its own common stock  in
the open market for $0.2 million during the first quarter of 1998
under  repurchase  programs intended  to  service  the  Company's
benefit  programs.   In anticipation of the planned  spin-off  of
SonoSight, the Company temporarily suspended all share repurchase
activities.   The  Company  repurchased 343,000  shares  totaling
$11.9  million  in  1997.  In May 1997, the  Board  of  Directors
authorized the Company to purchase up to 1,000,000 shares of  its
common stock, subject to certain criteria.

In  addition  to  its  cash balances, the Company  has  available
domestic  credit facilities of $35 million, including a committed
line   of   credit  of  $25  million.   Barring  any   unforeseen
circumstances  or  events,  management  expects  existing   cash,
available credit lines and funds from operations to be sufficient
to  meet  the  Company's  operating requirements  for  1998  (see
Forward Looking Information).

The  Company  began  construction of a new  101,000  square  foot
building  on its corporate campus in August 1997.  The building's
projected completion date is scheduled for July 1998 and  has  an
estimated  cost of $15 to $16 million.  Initial funding  for  the
project has come from working capital and will transition to long-
term debt as the building reaches completion in 1998.

The  Company spun-off its handheld business on April 6, 1998 (the
"Distribution").   In connection with the spin-off,  the  Company
contributed  capital of $18 million in cash on  the  Distribution
date  and  will contribute an additional $12 million in  cash  in
January 1999 (see Note 7 to the Condensed Consolidated  Financial  
Statements, Distribution and Subsequent Event).

                              12
<PAGE>

Item 2.     Management's  Discussion and  Analysis  of  Financial
            -----------------------------------------------------
            Condition and Results of Operations (Continued)
            -----------------------------------------------

FORWARD LOOKING INFORMATION
- ---------------------------

As  an update to the forward looking information provided in  the
Company's  1997  Annual  Report  to  Shareholders,  the   Company
provides the following information.

The  Company expects revenues in the second quarter  of  1998  to
approximate $109 to $111 million with a gross margin in excess of
50%.   Excluding handheld operating expenses, operating  expenses
are  anticipated to increase about 10% during this  period  as  a
result  of higher sales volumes, continuing infrastructure build-
up  in  Latin  America  and the timing of  various  programs  and
strategies.  EPS for the second quarter is expected to be in  the
range of $0.29 to $0.32 per share.  The Company believes it  will
continue to make progress towards its goal of achieving a  return
on equity of 15% by the end of 1998.

The   above  statements  and  other  statements  in  this  report
identified by cross reference to this section are forward looking
statements  that involve a number of risks and uncertainties  and
should  be  read  in conjunction with the Company's  1997  Annual
Report to Shareholders, which is incorporated by reference to the
Company's 1997 Form 10-K, and the Company's news releases.  Among
the  ongoing  factors that could cause actual results  to  differ
materially from the above are the following considerations.   The
ultrasound market in some European countries remains sluggish and
certain   Asian  markets  are  affected  by  turbulent   economic
conditions,  which  may cause revenue growth  to  fall  short  of
expectations.  Worldwide competition in the ultrasound market has
intensified  over  the  past  year, and  most  of  the  Company's
competitors  have introduced new ultrasound products  within  the
past two years.  The time required for customers to evaluate  the
many new products on the market may lengthen the sales cycle  for
ultrasound  purchases, and the Company may lose  sales  to  other
product  offerings.   These  factors  may  adversely  impact  the
Company's  sales volume or selling prices or both.  Unanticipated
events,  such as delays in the Company's product development  and
cost   reduction  programs,  the  unavailability  of   components
critical  to  the  Company's products due to  natural  disasters,
changes  in  vendor businesses or otherwise, economic instability
in  Asian and other markets, the stronger U.S. dollar, delays  in
receiving  necessary  regulatory approvals, or  other  unforeseen
events could adversely impact the Company's financial results for
1998.

                               13
<PAGE>

PART II   Other Information
- -------   -----------------



Item 1.   Legal Proceedings - None
          -----------------

Item 2.   Changes in Securities - None.
          ---------------------

Item 3.   Defaults Upon Senior Securities - None.
          -------------------------------

Item  4.  Submission of Matters to a Vote of Security Holders - None.
          ---------------------------------------------------

Item 5.   Other Information - None.
          -----------------

Item 6.   Exhibits and Reports on Form 8-K
          --------------------------------

          (a)  Exhibits - Financial Data Schedule
          (b)  Reports of Form 8-K - None.




                            SIGNATURE
                                
Pursuant  to the requirements of the Securities Exchange  Act  of
1934, the registrant has duly caused this report to be signed  on
its behalf by the undersigned thereunto duly authorized.




                                   ATL ULTRASOUND, INC.
                                       (Registrant)
                                             
                                             
                                             
Date:     May 14, 1998             BY:/s/Pamela L. Dunlap 
                                   -----------------------
                                     Pamela L. Dunlap
                         
                                   Senior Vice President
                                   Finance and Administration
                                   and Chief Financial Officer
           
                                14

        


<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
CONDENSED CONSOLIDATED BALANCE SHEET AS OF APRIL 3, 1998 AND THE
CONDENSED CONSOLIDATED STATEMENT OF OPERATION FOR THE THREE MONTHS ENDED
APRIL 3, 1998 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH
FINANICIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1998
<PERIOD-START>                              JAN-1-1998
<PERIOD-END>                                APR-3-1998
<CASH>                                          43,113
<SECURITIES>                                         0
<RECEIVABLES>                                  117,243
<ALLOWANCES>                                         0
<INVENTORY>                                     97,307
<CURRENT-ASSETS>                               275,229
<PP&E>                                          76,380
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                                 357,242
<CURRENT-LIABILITIES>                          120,215
<BONDS>                                         12,166
                                0
                                          0
<COMMON>                                             0
<OTHER-SE>                                           0
<TOTAL-LIABILITY-AND-EQUITY>                   357,242
<SALES>                                         81,999
<TOTAL-REVENUES>                               105,416
<CGS>                                           38,315
<TOTAL-COSTS>                                   52,619
<OTHER-EXPENSES>                                50,209
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 286
<INCOME-PRETAX>                                  2,728
<INCOME-TAX>                                       545
<INCOME-CONTINUING>                              2,183
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     2,183
<EPS-PRIMARY>                                      .15
<EPS-DILUTED>                                      .15
        

</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission